RP2-associated Retinitis Pigmentosa

Ophthalmology·MeSH: Retinitis Pigmentosa

Prevalence

25.0 / 100K

Incidence

1.5 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target RP2-associated Retinitis Pigmentosa?

There are 1 clinical trial targeting RP2-associated Retinitis Pigmentosa tracked by BioSniper.

What is the prevalence of RP2-associated Retinitis Pigmentosa?

The estimated prevalence of RP2-associated Retinitis Pigmentosa is approximately 25.0 per 100,000 population.

Deep-dive into RP2-associated Retinitis Pigmentosa

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    RP2-associated Retinitis Pigmentosa — Drugs in Development & Clinical Trials | BioSniper